Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-20T13:36:20.068Z Has data issue: false hasContentIssue false
  • English
  • Français

Naloxone treatment for opiate withdrawal syndrome

Published online by Cambridge University Press:  02 January 2018

N. Loimer ,
R. Schmid ,
O. Presslich  and
K. Lenz
N. Loimer
Affiliation:
Psychiatric University Hospital of Vienna Austria
R. Schmid
Affiliation:
Psychiatric University Hospital of Vienna Austria
O. Presslich
Affiliation:
Psychiatric University Hospital of Vienna Austria
K. Lenz
Affiliation:
Intensive Care Unit First Department of Internal Medicine University Hospital of Vienna Austria
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 153 , Issue 6 , December 1988 , pp. 851 - 852
Copyright
Copyright © Royal College of Psychiatrists, 1988 

References

Hendrie, C. A. (1985) Opiate dependence and withdrawal – a new synthesis? Pharmacology, Biochemistry and Behavior, 23, 863–870.Google Scholar
Jasinsky, D. R., Martin, W. R. & Haertzen, C. A. (1967) The human pharmacology and abuse potential of N-allylnoroxymor-phone (naloxone). Journal of Pharmacological and Experimental Therapy, 137, 420–426.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.